The C-terminal region of serotonin transporter is important for its trafficking and glycosylation

Journal of Pharmacological Sciences

Volumn 111, Issue 4, 2009, Pages 392-404

  Nobukuni, Mariko ^a   Mochizuki, Hideki ^a   Okada, Satoshi ^a   Kameyama, Nobuhisa ^a   Tanaka, Anna ^a   Yamamoto, Hikaru ^a   Amano, Taku ^a   Seki, Takahiro ^a   Sakai, Norio ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Endoplasmic reticulum stress; Glycosylation; Membrane trafficking; Plasma membrane; Serotonin transporter

Indexed keywords

BREFELDIN A; ILIMAQUINONE; MUTANT PROTEIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG INHIBITION; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENE DELETION; GENE OVEREXPRESSION; GLYCOSYLATION; MEMBRANE TRANSPORT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEROTONIN UPTAKE;

EID: 74849128326     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09195FP     Document Type: Article

References (53)

1. Stahl SM. Essential psychopharmacology: neuroscientific basis and practical applications. Second ed. Cambridge UK: Cambridge University Press; 2000.
2. Kuhar MJ, Roth RH, Aghajanian GK. Synaptosomes from forebrains of rats with midbrain raphe lesions: selective reduction of serotonin uptake. J Pharmacol Exp Ther. 1972;181:36-45.
3. Blakely RD, Berson HE, Fremeau RJ, Caron MG, Peek MM, Prince HK, et al. Cloning and expression of a functional serotonin transporter from rat brain. Nature. 1991;354:66-70.
4. Hoffman BJ, Mezey E, Brownstein MJ. Cloning of a serotonin transporter affected by antidepressants. Science. 1991;254:579-580.
5. Sodhi MS, Sanders-Bush E. Serotonin and brain development. Int Rev Neurobiol. 2004;59:111-174.
6. McLean PG, Borman RA, Lee K. 5-HT in the enteric nervous system: gut function and neuropharmacology. Trends Neurosci. 2007;30:9-13.
7. Douglas JG, Munro JF. Drug treatment and obesity. Pharmacol Ther. 1982;18:351-373.
8. Rowland NE, Carlton J. Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol. 1986;27:13-62.
9. Rudnick G, Wall SC. Binding of the cocaine analog 2 beta-[3H] carboxymethoxy-3 beta-(4-fluorophenyl)tropane to the serotonin transporter. Mol Pharmacol. 1991;40:421-426.
10. Rudnick G, Wall SC. Non-neurotoxic amphetamine derivatives release serotonin through serotonin transporters. Mol Pharmacol. 1993;43:271-276.
11. Capsi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386-389.
12. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527-1531.
13. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, et al. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet. 2005;77:265-279.
14. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, et al. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry. 2003;8:933-936.
15. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci U S A. 1993;90:2542-2546.
16. Tate CG, Blakely RD. The effect of N-linked glycosylation on activity of the Na(+)- and Cl(-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J Biol Chem. 1994;269:26303-26310.
17. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci. 2005;25:29-41.
18. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem. 2005;280:15649-15658.
19. Zhu CB, Hewlett WA, Feoktistov I, Biaggioni I, Blakely RD. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol. 2004;65:1462-1474.
20. Haase J, Killian AM, Magnani F, Williams C. Regulation of the serotonin transporter by interacting proteins. Biochem Soc Trans. 2001;29:722-728.
21. Jess U, El Far O, Kirsch J, Betz H. Interaction of the C-terminal region of the rat serotonin transporter with MacMARCKS modulates 5-HT uptake regulation by protein kinase C. Biochem Biophys Res Commun. 2002;294:272-279.
22. Carneiro AM, Blakely RD. Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter. J Biol Chem. 2006;281:24769-24780.
23. Muller HK, Wiborg O, Haase J. Subcellular redistribution of the serotonin transporter by secretory carrier membrane protein 2. J Biol Chem. 2006;281:28901-28909.
24. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, et al. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci U S A. 2007;104:8119-8124.
25. Ahmed BA, Jeffus BC, Bukhari SI, Harney JT, Unal R, Lupashin VV, et al. Serotonin transamidates Rab4 and facilitates its binding to the C terminus of serotonin transporter. J Biol Chem. 2008;283:9388-9398.
26. Fjorback AW, Muller HK, Wiborg O. Membrane glycoprotein M6B interacts with the human serotonin transporter. J Mol Neurosci. 2009;37:191-200.
27. Wersinger C, Rusnak M, Sidhu A. Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur J Neurosci. 2006;24:55-64.
28. Carneiro AM, Cook EH, Murphy DL, Blakely RD. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest. 2008;118:1544-1552.
29. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, et al. Human serotonin transporter variants display altered sensitivity to protein kinase G and p38 mitogen-activated protein kinase. Proc Natl Acad Sci U S A. 2005;102:11545-11550.
30. Mochizuki H, Amano T, Seki T, Matsubayashi H, Mitsuhata C, Morita K, et al. Role of C-terminal region in the functional regulation of rat serotonin transporter (SERT). Neurochem Int. 2005;46:93-105.
31. Larsen MB, Fjorback AW, Wiborg O. The C-terminus is critical for the functional expression of the human serotonin transporter. Biochemistry. 2006;45:1331-1337.
32. Sogawa C, Kumagai K, Sogawa N, Morita K, Dohi T, Kitayama S. C-terminal region regulates the functional expression of human noradrenaline transporter splice variants. Biochem J. 2007;401:185-195.
33. Kitayama S, Dohi T. Cellular and molecular aspects of monoamine neurotransmitter transporters. Jpn J Pharmacol. 1996;72:195-208.
34. Kitayama S, Sogawa C. Regulated expression and function of the somatodendritic catecholamine neurotransmitter transporters. J Pharmacol Sci. 2005;99:121-127.
35. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Molecular pathways to neurodegeneration. Nat Med. 2004;10 Suppl:S2-S9.
36. Paschen W, Mengesdorf T. Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease - therapeutic potential. Pharmacol Ther. 2005;108:362-375.
37. Paschen W, Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium. 2005;38:409-415.
38. Sakai N, Sasaki K, Nakashita M, Honda S, Ikegaki N, Saito N. Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/threonine phosphatases. J Neurochem. 1997;68:2618-2624.
39. Seki T, Adachi N, Ono Y, Mochizuki H, Hiramoto K, Amano T, et al. Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death. J Biol Chem. 2005;280:29096-29106.
40. Klausner RD, Donaldson JG, Lippincott-Schwartz J. Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol. 1992;116:1071-1080.
41. Nebenfuhr A, Ritzenthaler C, Robinson DG. Brefeldin A: deciphering an enigmatic inhibitor of secretion. Plant Physiol. 2002;130:1102-1108.
42. Takizawa PA, Yucel JK, Veit B, Faulkner DJ, Deerinck T, Soto G, et al. Complete vesiculation of Golgi membranes and inhibition of protein transport by a novel sea sponge metabolite, ilimaquinone. Cell. 1993;73:1079-1090.
43. Veit B, Yucel JK, Malhotra V. Microtubule independent vesiculation of Golgi membranes and the reassembly of vesicles into Golgi stacks. J Cell Biol. 1993;122:1197-1206.
44. Axelsson MA, Warren G. Rapid, Endoplasmic reticulumin-dependent diffusion of the mitotic Golgi haze. Mol Biol Cell. 2004;15:1843-1852.
45. Strous GJ, van Kerkhof P, van Meer G, Rijnboutt S, Stoorvogel W. Differential effects of brefeldin A on transport of secretory and lysosomal proteins. J Biol Chem. 1993;268:2341-2347.
46. Yamamoto H, Fujimiya M, Shirai Y, Nakashita M, Oyasu M, Saito N. Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain. Neurosci Res. 1998;32:305-312.
47. Zhao S, Edwards J, Carroll J, Wiedholz L, Millstein RA, Jaing C, et al. Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice. Neuroscience. 2006;140:321-334.
48. Miranda M, Sorkina T, Grammatopoulos TN, Zawada WM, Sorkin A. Multiple molecular determinants in the carboxyl terminus regulate dopamine transporter export from endoplasmic reticulum. J Biol Chem. 2004;279:30760-30770.
49. Stockklausner C, Ludwig J, Ruppersberg JP, Klocker N. A sequence motif responsible for ER export and surface expression of Kir2.0 inward rectifier K(+) channels. FEBS Lett. 2001;493:129-133.
50. Chang XB, Cui L, Hou YX, Jensen TJ, Aleksandrov AA, Mengos A, et al. Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis. Mol Cell. 1999;4:137-142.
51. O'Kelly I, Butler MH, Zilberberg N, Goldstein SA. Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell. 2002;111:577-588.
52. Margeta-Mitrovic M, Jan YN, Jan LY. A trafficking checkpoint controls GABA(B) receptor heterodimerization. Neuron. 2000;27:97-106.
53. Barlowe C. Signals for COPII-dependent export from the ER: what's the ticket out? Trends Cell Biol. 2003;13:295-300.